Khalafallah, A. A., Fernandopulle, B. and Brain, T. (2010) “Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia”, Mediterranean Journal of Hematology and Infectious Diseases, 2(2), p. e2010012. doi: 10.4084/mjhid.2010.012.